Overview

OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The study compares the analgesic efficacy of OXN PR vs placebo in opioid-naive subjects suffering from severe pain due to Bladder Pain Syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Mundipharma Research GmbH & Co KG
Treatments:
Naloxone
Oxycodone